Related Experiment Video
Updated: Sep 9, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma
1Norman Bethune University of Medical Sciences, Department of ENT & HN, First Clinical Hospital, Chang-Chun, Ji Lin, 130021, P.R. China. dubo2000@hotmail.com
Abstract:
Membrane type 1-matrix metalloproteinase (MT1-MMP) is a member of the recently identified unique membrane-type subgroup in the matrix metalloproteinase (MMP) family. MT1-MMP has proteolytic activity against components of the extracellular matrix and activates progelatinase A (MMP-2) at the cell surface. In this study, we analyzed the expression of MT1-MMP mRNA in 45 cases of laryngeal carcinoma by RT-PCR and investigated the relationship between MT1-MMP expression and survival in 18 cases. The result showed that the expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue. The tumoral expression in clinical stage III was higher than in stage II. The tumoral expression level of MT1-MMP mRNA in patients with lymph node metastasis was signigicantly higher than those with negative lymph nodes. The patients with high expression level showed significantly poorer 5 year survival than those with low expression level. Collectively, our findings suggest that the high level of MT1-MMP expression is closely related to the invasion and metastasis of laryngeal carcinoma, and indicates poorer prognosis.
Insights
High expression of membrane type 1-matrix metalloproteinase (MT1-MMP) in laryngeal carcinoma correlates with advanced disease and poorer survival. This suggests MT1-MMP may drive tumor invasion and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Membrane type 1-matrix metalloproteinase (MT1-MMP) is a key enzyme involved in extracellular matrix degradation.
- MT1-MMP plays a role in cell surface progelatinase A (MMP-2) activation.
- Understanding MT1-MMP's role in cancer is crucial for prognosis.
Purpose of the Study:
- To analyze MT1-MMP mRNA expression in laryngeal carcinoma.
- To investigate the correlation between MT1-MMP expression and clinicopathological features.
- To determine the relationship between MT1-MMP expression and patient survival.
Main Methods:
- Reverse transcription polymerase chain reaction (RT-PCR) was used to quantify MT1-MMP mRNA levels.
- Expression analysis was performed on 45 laryngeal carcinoma tissue samples.
- Survival analysis was conducted on 18 of these cases.
Main Results:
- MT1-MMP mRNA expression was significantly higher in tumor tissues compared to normal tissues.
- Expression levels increased with clinical stage (Stage III > Stage II).
- Higher MT1-MMP expression was observed in patients with lymph node metastasis.
- Elevated MT1-MMP expression was associated with significantly poorer 5-year survival.
Conclusions:
- High MT1-MMP expression is linked to increased invasion and metastasis in laryngeal carcinoma.
- MT1-MMP serves as a potential biomarker for poor prognosis in laryngeal cancer.
- Targeting MT1-MMP could be a therapeutic strategy for laryngeal carcinoma.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role of Matrix Metalloproteases in Degradation of ECM
A...

